Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Histone modification is key in treating chronic inflammatory skin diseases.

Aged individuals heal wounds less effectively due to specific immune cell issues.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Vitamin D is important for skin health and can help improve various skin conditions.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Probiotics may help treat skin conditions like acne and eczema safely.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Microneedling, especially with halometasone, improves hair regrowth and gut health in alopecia areata.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.